Skip to main content

Total statutory rebates and fees for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars)

Total statutory rebates and fees for brand medicines in US by component 2013-2020

Jan 31, 2022
United States
Aprajita Minhas
From 01/01/2013 to 31/12/2020

Related insights

StatisticUSA
Market access rebates and discounts for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars)
Premium StatisticUSA
Pharmacy rebates of Medicaid outpatient prescription drugs in the U.S. from fiscal year 2019 to 2024 (in billion U.S. dollars)
Premium StatisticUSA
Share of Medicaid prescription drug rebate in the U.S. from fiscal year 2019 to 2024, by type
StatisticUSA
Total point of sale payments for brand medicines in the U.S. from 2013 to 2020 (in billion U.S. dollars)
StatisticUSA
Total wholesaler and provider margins for brand medicines in the U.S. from 2013 to 2020, by component (in billion U.S. dollars)
StatisticUSA
Share of total brand medicine expenditures retained by manufacturers and other entities in the U.S. from 2013 to 2020
StatisticUSA
Total value of pharmaceutical gross-to-net reductions in the U.S. from 2019 to 2024 (in billion U.S. dollars)
StatisticUSA
Share of increase in U.S. brand medicine gross expenditures in 2019-2020, by entity
Premium StatisticUSA
Global medicinal market growth including rebates from 2009 to 2018 (in billion U.S. dollars)
Premium StatisticUSA
Medicare spending on advertised and non-advertised drugs from 2016 to 2018* (in billion U.S. dollars)
StatisticUSA
Medicare Part B and Part D spending on advertised drugs from 2016 to 2018 (in billion U.S. dollars)
StatisticUSA
New medicine brands spending in the U.S. from 2012 to 2021 (in billion U.S. dollars)
Premium StatisticUSA
Average price growth for branded drugs in the U.S. from 2011 to 2019*
StatisticUSA
Change in branded and generic medication spending in the United States from 2014 to 2021 (in billion U.S. dollars)
Premium StatisticUSA
Medicaid spending on prescription drugs in the United States from 1970 to 2024 (in billion U.S. dollars)
StatisticUSA
Medicaid PMPM spending on medical drug claims from 2018 to 2021 (in U.S. dollars)
StatisticUSA
Medicare PMPM spending on medical drug claims from 2018 to 2021 (in U.S. dollars)
Premium StatisticUSA
Savings through generic drug usage in the United States in 2024, by payer (in billion U.S. dollars)
StatisticUSA
Projected drug expenditures under three levels of Pharmacy Benefit Management (PBM) use in the U.S. for the period 2023-2032, by payer (in billion U.S. dollars)
Premium StatisticUSA
Brand and generic prescription medication spending in the U.S. from 2006 to 2021 (in billion U.S. dollars)
Premium StatisticUSA
Medicare spending on prescription drugs in the United States from 1970 to 2024 (in billion U.S. dollars)
Premium StatisticUSA
Total Medicaid gross spending on outpatient prescription drugs from FY 2017 to FY 2024 (in billion U.S. dollars)
Premium StatisticUSA
Total Medicaid net spending on outpatient prescription drugs from FY 2017 to FY 2024 (in billion U.S. dollars)
Premium StatisticUSA
Savings through generic drug usage in the United States from 2008 to 2024 (in billion U.S. dollars)
StatisticUSA
Medical loss ratio (MLR) rebates per member of commercial health insurance in the U.S. from 2010 to 2020, by market* (in U.S. dollars)
StatisticUSA
Projected annual Medicare & Medicaid spending on Alzheimer's, with and without new treatment advances 2010-2050 (in billion U.S. dollars)*
Premium StatisticUSA
WAC spending on medicines in the U.S. from 2015 to 2029 (in billion U.S. dollars)
StatisticFRA
Revenue from reimbursable pharmaceutical products in France from 2005 to 2018, at manufacturer prices excluding taxes (in millions of euros)
StatisticUSA
Share of Rx drug dollar spending by drug supply chain participants in the U.S. in 2023
StatisticUSA
Cost-sharing for generic and brand name drugs in the Medicare Part D coverage gap in 2019
TopicUSA
Prescription drug plans in the U.S.- Statistics and Facts
Premium ReportUSA
Prescription drug plans in the U.S.
TopicUSA
U.S. pharmaceutical industry - statistics & facts
TopicUSA
Pharmaceutical and medical device recalls - Statistics & Facts
TopicUSA
Drug prices in the U.S. - Statistics & Facts
Premium ReportUSA
Pharmacy benefit managers (PBMs)
TopicWorldwide
Generics and biosimilars in the U.S. - Statistics & Facts
Infographic
Few Pricey Medications Cause Bulk of Medicare Drug Spending
TopicUSA
Health regulations in the U.S. - Statistics & Facts
Infographic
U.S. Prescriptions Meds Pricey for Government and Households
TopicNLD
Pharmaceutical market in the Netherlands - Statistics & Facts
TopicUSA
Pharma and healthcare industry advertising in the U.S. - statistics & facts
TopicUSA
Health expenditures in the U.S. – statistics & facts
Infographic
Americans Spend Much More on Pharmaceuticals
TopicUSA
Medicare - Statistics & Facts
Premium ReportUSA
Drug prices in the U.S.
Premium ReportUSA
Pharma and healthcare industry advertising in the U.S.
TopicUSA
Rite Aid - statistics & facts
Premium ReportUSA
Rite Aid
Infographic
The Ever-Increasing Cost of Medicare Drugs
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch